| Title |
|
|
|
Can positron emission tomography with []-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?
| |
| Author |
|
|
|
| |
| Abstract |
|
|
| | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
British journal of haematology. - Oxford | |
| Publication |
|
|
|
Oxford : 2001
| |
| ISSN |
|
|
|
0007-1048
| |
| Volume/pages |
|
|
|
115:2(2001), p. 272-278
| |
| ISI |
|
|
|
000172403300007
| |
| Full text (Publisher's DOI) |
|
|
| | |
| Full text (publisher's version - intranet only) |
|
|
| | |
|